InvestorsHub Logo
Followers 54
Posts 11813
Boards Moderated 1
Alias Born 07/07/2017

Re: OPKOHEALTH2022 post# 6410

Sunday, 07/15/2018 7:22:34 PM

Sunday, July 15, 2018 7:22:34 PM

Post# of 60456
Agreed, they have enough cash to run at current run rate through 2019 and even through 2020. However, they are going to need to ramp up production if the sign contracts for LIPA and CT. They were already stating that was the plan. Cash burn is about $12 million per quarter. If the ramp up, that likely raises cash burn unless they have sales to cover. Hence we need another sale within the next 6 months so we don't need to consider raising money other ways. The $50 million shelf offering app submitted last month was specifically to untilize to fullfil a large order if the need arises, ie: LIPA and or CT RFPs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FCEL News